Beauty Farm Medical spends HK$1.04 million to repurchase 52,500 shares on 8 May 2026

Bulletin Express05-08

Beauty Farm Medical and Health Industry Inc. completed an on-market repurchase of 52,500 ordinary shares on 8 May 2026, paying a total of HK$1.04 million. The transaction was executed on the Hong Kong Stock Exchange at prices ranging from HK$19.57 to HK$20.04 per share, with a volume-weighted average cost of HK$19.89.

Following the buyback, the company’s issued share capital (excluding treasury shares) fell by 0.021% to 249.64 million shares. Treasury shares increased to 1.95 million, while the total number of issued shares remained unchanged at 251.59 million.

The repurchase forms part of a mandate approved on 27 June 2025 that authorises the company to buy back up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 1.95 million shares, equivalent to 0.83% of the company’s issued share base on the mandate date. Under Hong Kong listing rules, Beauty Farm Medical is restricted from issuing new shares or selling treasury shares until 7 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment